467 results
8-K
EX-2.1
v5pb 745s2ybp5s0hec
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.1
umgqg6n
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-3.1
xbq5rux0odq4 ygow
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
NT 10-K
5ggufvzz
2 Apr 24
Notice of late annual filing
5:29pm
8-K
w34wja9vq4ihkc2h5
22 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:45pm
8-K
EX-1.1
9ueeuc08cbyu 3bdljan
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
424B5
9t1fijjhg
9 Nov 23
Prospectus supplement for primary offering
4:11pm